Ранняя оценка исходов инсульта по сравнению с поздней

К.Р. Лис, М.Г. Селим, К.А. Молина, Дж.П. Бродерик

Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, Gardiner Institute, Western Infirmary, University of Glasgow, Glasgow, United Kingdom; Department of Neurology, University of Cincinnati Neuroscience Institute, OH; Stroke Division, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA; and Stroke Unit, Department of Neurology, Hospital Vall d’Hebron-Barcelona, Barcelona, Spain.


  1. Hong K.S., Saver J.L. Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights ­for each level of the modified Rankin Scale. Stroke. 2009;40:3828–3833. doi: 10.1161/STROKEAHA.109.561365.
  2. Vahedi K., Vicaut E., Mateo J., Kurtz A., Orabi M., Guichard J.P., et al; DECIMAL Investigators. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy ­in malignant middle cerebral artery infarction (DECIMAL trial). Stroke. 2007;38:2506–2517. doi: 10.1161/STROKEAHA.107.485235.
  3. Berkhemer O.A., Fransen P.S., Beumer D., van den Berg L.A., Lingsma H.F., Yoo A.J., et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20. doi: 10.1056/NEJMoa1411587.
  4. Goyal M., Demchuk A.M., Menon B.K., Eesa M., Rempel J.L., Thornton J., et al; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–1030. doi: 10.1056/NEJMoa1414905.
  5. Lees K.R., Bath P.M., Schellinger P.D., Kerr D.M., Fulton R., HackeW., et al; European Stroke Organization Outcomes Working Group. Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke. 2012;43:1163–1170. ­doi: 10.1161/STROKEAHA.111.641423.
  6. Emberson J., Lees K.R., Lyden P., Blackwell L., Albers G., et al; Stroke Thrombolysis Trialists’ Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis ­of individual patient data from randomised trials. Lancet. 2014; 379: 2352–2363. doi:10.1016/S0140-6736(14)60584-5.
  7. MacIsaac R.L., Khatri P., Bendszus M., Bracard S., Broderick J., Campbell B., et al; VISTA Endovascular Collaboration. A collaborative sequential metaanalysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: statistical analysis plan for a sequential metaanalysis performed within the VISTA-Endovascular collaboration. Int J Stroke. 2015;10(suppl A100):136–144. doi: 10.1111/ijs.12622.
  8. Palesch Y.Y., Yeatts S.D., Tomsick T.A., Foster L.D., Demchuk A.M., Khatri P., et al; Interventional Management of Stroke III Investigators. Twelvemonth clinical and quality-of-life outcomes in the Interventional Management of Stroke III trial. Stroke. 2015;46:1321–1327. ­doi: 10.1161/STROKEAHA.115.009180.
  9. MISTIE II results. American Heart Association website: https://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_436205.pdf. Accessed November 24, 2015.
  10. MISTIE II: 365-day results demonstrate improved outcome and cost benefit. American Heart Association website: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_449049.pdf. Accessed November 24, 2015.
  11. Wilson D.A., Nakaji P., Albuquerque F.C., McDougall C.G., Zabramski J.M., Spetzler R.F. Time course of recovery following poor-grade SAH: the incidence of delayed improvement and implications for SAH outcome study design. J Neurosurg. 2013;119:606–612. doi: 10.3171/2013.4.JNS121287.
  12. Kong K.H., Lee J. Temporal recovery and predictors of upper limb dexterity in the first year of stroke: a prospective study of patients admitted to a rehabilitation centre. NeuroRehabilitation. 2013;32:345–350. doi: 10.3233/NRE-130854.
  13. Kwiatkowski T., Libman R., Frankel M., Tilley B., Morganstern L., et al; NINDS rt-PA Stroke Study Group. The NINDS rt-PA stroke study: sustained benefit at one year. Stroke. 1998; 29:288.
  14. Fagan S.C., Morgenstern L.B., Petitta A., Ward R.E., Tilley B.C., Marler J.R., et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology. 1998;50:883–890.
  15. Ganesalingam J., Pizzo E., Morris S., Sunderland T., Ames D., Lobotesis K. Cost-utility analysis of mechanical thrombectomy using stent retrievers in acute ischemic stroke. Stroke. 2015;46:2591–2598. doi: 10.1161/STROKEAHA.115.009396.

Похожие статьи

Бионика Медиа